Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21118757.
- Also identified by DOI 10.1109/TBME.2010.2095851 and PMC identifier 3187616.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atlas Genetics has developed a point-of-care device for Chlamydia trachomatis utilizing a novel electrochemical detection principle. The assay has a time-to-result of less than 25 min. An independent preclinical validation study using 306 pretyped clinical samples determined a clinical sensitivity of 98.1% and specificity of 98.0%.
Medical subject headings
- Chlamydia trachomatis
- Electrochemical Techniques
- Microfluidic Analytical Techniques
- Point-of-Care Systems